T1	PROC 509 531	Determinar la eficacia
#1	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
T2	DISO 105 124	artritis reumatoide
#2	AnnotatorNotes T2	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T3	PROC 826 850	Se determinó la eficacia
#3	AnnotatorNotes T3	C1707887; Efficacy Study; Research Activity
T4	DISO 144 163	artritis reumatoide
#4	AnnotatorNotes T4	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T5	DISO 171 192	enfermedad autoinmune
#5	AnnotatorNotes T5	C0004364; Autoimmune Diseases; Disease or Syndrome
T6	CHEM 227 267	anticuerpos contra péptidos citrulinados
#6	AnnotatorNotes T6	C4318437; Anti-Cyclic Citrullinated Protein Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T7	PROC 902 904	FR
#7	AnnotatorNotes T7	C0201660; Rheumatoid Factor Measurement; Laboratory Procedure
T8	PROC 305 316	diagnóstico
#8	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	DISO 323 333	enfermedad
#9	AnnotatorNotes T9	C0012634; Disease; Disease or Syndrome
T10	PROC 419 430	anticuerpos
#10	AnnotatorNotes T10	C0201278; Antibody measurement; Laboratory Procedure
T11	PROC 439 450	diagnóstico
#11	AnnotatorNotes T11	C0011900; Diagnosis; Diagnostic Procedure
T12	DISO 476 495	artritis reumatoide
#12	AnnotatorNotes T12	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T13	PROC 539 600	ensayos de determinación de anticuerpos anti-CCP2 y anti-CCP3
T14	CHEM 567 588	anticuerpos anti-CCP2
T15	PROC 609 620	diagnóstico
#13	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	DISO 646 665	artritis reumatoide
#14	AnnotatorNotes T16	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T17	DISO 719 738	artritis reumatoide
#15	AnnotatorNotes T17	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T18	DISO 763 802	enfermedades reumáticas e inflamatorias
#16	AnnotatorNotes T18	C1290884; Inflammatory disorder; Disease or Syndrome + C0035435; Rheumatism; Disease or Syndrome
T19	CHEM 1070 1079	anti-CCP2
T20	PROC 870 900	anticuerpos factor reumatoideo
#17	AnnotatorNotes T20	C0201660; Rheumatoid Factor Measurement; Laboratory Procedure
T21	CHEM 1263 1272	anti-CCP2
T22	PROC 946 951	ELISA
#18	AnnotatorNotes T22	C0014441; Enzyme-Linked Immunosorbent Assay; Laboratory Procedure
T23	PROC 1063 1079	ensayo anti-CCP2
T24	PROC 1230 1232	FR
#19	AnnotatorNotes T24	C0201660; Rheumatoid Factor Measurement; Laboratory Procedure
T25	PROC 1255 1272	ensayos anti-CCP2
T26	PROC 1275 1277	FR
#20	AnnotatorNotes T26	C0201660; Rheumatoid Factor Measurement; Laboratory Procedure
T27	PROC 1321 1336	autoanticuerpos
#21	AnnotatorNotes T27	C1272321; Autoantibody measurement; Laboratory Procedure
T28	PROC 1365 1384	proteína C reactiva
#22	AnnotatorNotes T28	C0201657; C-reactive protein measurement; Laboratory Procedure
T29	PROC 1406 1441	velocidad de sedimentación globular
#23	AnnotatorNotes T29	C1176468; Erythrocyte sedimentation rate measurement; Laboratory Procedure (?)
T30	PROC 907 916	anti-CCP2
T31	PROC 1457 1478	anticuerpos anti-CCP2
T32	PROC 919 928	anti-CCP3
T33	PROC 1570 1591	anticuerpos anti-CCP2
T34	PROC 1626 1637	diagnóstico
#24	AnnotatorNotes T34	C0011900; Diagnosis; Diagnostic Procedure
T35	DISO 1663 1682	artritis reumatoide
#25	AnnotatorNotes T35	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T36	CHEM 1704 1706	FR
#26	AnnotatorNotes T36	C0035448; Rheumatoid Factor; Immunologic Factor · Amino Acid, Peptide, or Protein
T37	DISO 1741 1760	artritis reumatoide
#27	AnnotatorNotes T37	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T38	PROC 1778 1799	anticuerpos anti-CCP2
T39	PROC 1836 1849	inmunoensayos
#28	AnnotatorNotes T39	C0020980; Immunoassay method; Laboratory Procedure
T40	PROC 25 62	anticuerpos antipéptidos citrulinados
#29	AnnotatorNotes T40	C1318660; Anti-cyclic citrullinated peptide antibody level; Laboratory Procedure
T41	CHEM 591 600	anti-CCP3
T42	PROC 1687 1706	determinación de FR
#30	AnnotatorNotes T42	C0201660; Rheumatoid Factor Measurement; Laboratory Procedure
T43	LIVB 454 463	pacientes
#31	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	LIVB 624 633	pacientes
#32	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	LIVB 705 714	pacientes
#33	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 743 752	pacientes
#34	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 808 818	individuos
#35	AnnotatorNotes T47	C0027361; Persons; Population Group
T56	LIVB 1641 1650	pacientes
#36	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 1727 1736	pacientes
#37	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T48	Quantifier_or_Qualifier 63 96	de segunda y tercera generaciones
R1	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T48	
R4	Used_for Arg1:T6 Arg2:T8	
R6	Experiences Arg1:T43 Arg2:T10	
R8	Before Arg1:T43 Arg2:T12	
R9	Experiences Arg1:T44 Arg2:T13	
R11	Experiences Arg1:T44 Arg2:T16	
R14	Experiences Arg1:T45 Arg2:T17	
R15	Experiences Arg1:T46 Arg2:T18	
T49	Quantifier_or_Qualifier 819 824	sanos
#38	AnnotatorNotes T49	C3898900; Healthy; Qualitative Concept
R16	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T49	
T50	CONC 974 986	sensibilidad
#39	AnnotatorNotes T50	C0439823; Sensibility; Qualitative Concept
T51	CONC 988 1001	especificidad
#40	AnnotatorNotes T51	C0037791; Specificity; Quantitative Concept
T52	CONC 1003 1032	valores predictivos positivos
#41	AnnotatorNotes T52	C1514243; Positive Predictive Value; Quantitative Concept
T53	CONC 1003 1022;1035 1044	valores predictivos negativos
#42	AnnotatorNotes T53	C1513918; Negative Predictive Value of Diagnostic Test; Quantitative Concept
T54	CONC 1104 1116	sensibilidad
#43	AnnotatorNotes T54	C0439823; Sensibility; Qualitative Concept
T55	CONC 1209 1221	sensibilidad
#44	AnnotatorNotes T55	C0439823; Sensibility; Qualitative Concept
T58	CONC 1127 1140	especificidad
#45	AnnotatorNotes T58	C0037791; Specificity; Quantitative Concept
T59	CONC 1168 1181	especificidad
#46	AnnotatorNotes T59	C0037791; Specificity; Quantitative Concept
T60	CONC 1289 1302	especificidad
#47	AnnotatorNotes T60	C0037791; Specificity; Quantitative Concept
T61	CONC 1542 1548	DAS 28
#48	AnnotatorNotes T61	C2732493; Disease activity score 28 joint in rheumatoid arthritis; Intellectual Product
R17	Experiences Arg1:T56 Arg2:T33	
R19	Experiences Arg1:T56 Arg2:T35	
R20	Experiences Arg1:T57 Arg2:T42	
R21	Experiences Arg1:T57 Arg2:T37	
T62	Result_or_Value 1761 1774	seronegativos
#49	AnnotatorNotes T62	C0521144; Seronegative; Laboratory or Test Result
R23	Experiences Arg1:T57 Arg2:T38	
R24	Experiences Arg1:T57 Arg2:T39	
R25	Combined_with Arg1:T42 Arg2:T38	
R26	Combined_with Arg1:T25 Arg2:T26	
R27	Combined_with Arg1:T20 Arg2:T30	
R28	Combined_with Arg1:T20 Arg2:T32	
R29	Combined_with Arg1:T7 Arg2:T30	
R30	Combined_with Arg1:T7 Arg2:T32	
T63	Neg_cue 1479 1481	no
T64	CONC 1492 1503	correlación
A1	Assertion T64 Negated
#50	AnnotatorNotes T64	C1707520; Correlation; Qualitative Concept
R31	Negation Arg1:T63 Arg2:T64	
A2	Experiencer T57 Patient
A3	Experiencer T56 Patient
A4	Experiencer T43 Patient
A5	Experiencer T44 Patient
A6	Experiencer T47 Patient
A7	Experiencer T46 Patient
A8	Experiencer T45 Patient
R2	Has_Result_or_Value Arg1:T38 Arg2:T62	
